QR Pharma Receives Seed Investment from Ben Franklin Technology Partners for Further Development of Clinical Stage Compounds to Treat Alzheimer’s Disease

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply